Cazzola M - Search Results

1

Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.

Novelli F, Latorre M, Vergura L, Caiaffa MF, Camiciottoli G, Guarnieri G, Matucci A, Macchia L, Vianello A, Vultaggio A, Celi A, Cazzola M, Paggiaro P; Xolair Italian Study Group. Novelli F, et al. Among authors: cazzola m. Pulm Pharmacol Ther. 2015 Apr;31:123-9. doi: 10.1016/j.pupt.2014.09.007. Epub 2014 Sep 30. Pulm Pharmacol Ther. 2015. PMID: 25281265

2

Problems and prospectives in the antibiotic treatment of lower respiratory tract infections.

Cazzola M. Cazzola M. Pulm Pharmacol. 1994 Jun;7(3):139-52. doi: 10.1006/pulp.1994.1017. Pulm Pharmacol. 1994. PMID: 7827433 Review. No abstract available.

3

The use of bronchodilators in stable chronic obstructive pulmonary disease.

Cazzola M, Spina D, Matera MG. Cazzola M, et al. Pulm Pharmacol Ther. 1997 Jun;10(3):129-44. doi: 10.1006/pupt.1997.0087. Pulm Pharmacol Ther. 1997. PMID: 9514624 Review. No abstract available.

4

Pharmacological Control of Airways in Health and Diseases. Capri, Italy, October 1998. Preface.

Cazzola M. Cazzola M. Pulm Pharmacol Ther. 1998 Oct-Dec;11(5-6):317-8. Pulm Pharmacol Ther. 1998. PMID: 10210649 No abstract available.

5

Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.

Cazzola M, Matera MG, Noschese P. Cazzola M, et al. Pulm Pharmacol Ther. 2000;13(6):249-56. doi: 10.1006/pupt.2000.0253. Pulm Pharmacol Ther. 2000. PMID: 11061979 Review.

6

Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction.

Cazzola M, Grella E, Matera MG, Mazzarella G, Marsico SA. Cazzola M, et al. Pulm Pharmacol Ther. 2002;15(2):97-102. doi: 10.1006/pupt.2001.0336. Pulm Pharmacol Ther. 2002. PMID: 12090782 Clinical Trial.

7

Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.

Canonica GW, Castellani P, Cazzola M, Fabbri LM, Fogliani V, Mangrella M, Moretti A, Paggiaro P, Sanguinetti CM, Vignola AM; CAST (Control Of Asthma By Symbicort Turbuhaler) Study Group. Canonica GW, et al. Among authors: cazzola m. Pulm Pharmacol Ther. 2004;17(4):239-47. doi: 10.1016/j.pupt.2004.04.006. Pulm Pharmacol Ther. 2004. PMID: 15219269 Clinical Trial.

8

Potential genetic influences on the response to asthma treatment.

Pelaia G, Vatrella A, Gallelli L, Cazzola M, Maselli R, Marsico SA. Pelaia G, et al. Among authors: cazzola m. Pulm Pharmacol Ther. 2004;17(5):253-61. doi: 10.1016/j.pupt.2004.04.005. Pulm Pharmacol Ther. 2004. PMID: 15477120 Review.

9

Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma.

Vatrella A, Ponticiello A, Pelaia G, Parrella R, Cazzola M. Vatrella A, et al. Among authors: cazzola m. Pulm Pharmacol Ther. 2005;18(2):89-92. doi: 10.1016/j.pupt.2004.09.033. Epub 2004 Dec 8. Pulm Pharmacol Ther. 2005. PMID: 15649850 Clinical Trial.

10

A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.

Cazzola M, Rogliani P, Curradi G, Segreti A, Ciaprini C, Pezzuto G, Saltini C. Cazzola M, et al. Pulm Pharmacol Ther. 2009 Dec;22(6):522-5. doi: 10.1016/j.pupt.2009.05.005. Epub 2009 May 27. Pulm Pharmacol Ther. 2009. PMID: 19481169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,247 results

Search Page

Filters